🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

BDTX-189, BDTX-1535, BDTX-4933

Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.

Tags: biotechnology, cancer treatment, genetically defined tumors, small molecule inhibitors

Website

Vision/Values | About | About | Directors | Contact | Careers | Jobs | About

Symbol: BDTX

Recent Price: $2.15

Industry: Biotechnology

CEO: Dr. Mark A. Velleca M.D., Ph.D.

Sector: Healthcare

Employees: 54

Address: One Main Street, Cambridge, MA 02142

Phone: 617 252 0848

Leadership

  • Ali Behbahani, M.D., Co-Head of Healthcare, NEA
  • Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
  • Kapil Dhingra, M.D., Former Head, Roche Oncology Development
  • Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
  • Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
  • Prakash Raman, Ph.D., CEO of InduPro, Inc.
  • Mark A. Velleca, M.D., Ph.D., CEO and Board Chair

Last updated: 2024-12-31